Positive Results for Odronextamab in Relapsed/Refractory DLBCL

But experts aren't sure where it would fit in with currently approved bispecifics

Related Keywords

United States ,Kami Maddocks ,Kamij Maddocks ,Yazeed Sawalha ,Yazeedy Sawalha ,Ohio State University Wexner Medical Center ,Ohio State University James Comprehensive Cancer Center ,Ohio State University ,American Society Of Hematology ,American Society ,Medpage Today ,Im Yazeed Sawalha ,Ohio State ,Kim David ,